#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

News

psoriaza

Bimekizumab in the treatment of moderate to severe hidradenitis suppurativa – another approved indication for this biological agent

1. 7. 2024 Source: Psoriasis

In May, the primary results of the BE HEARD I and II studies evaluating the efficacy and safety of the IL-17A and IL-17F inhibitor bimekizumab in the treatment of moderate to severe hidradenitis suppurativa (HS) in adults were published in The Lancet. This is the first publication of the results of these Phase III studies. Based on these findings, the European Medicines Agency (EMA) approved bimekizumab (which is currently approved for the treatment of plaque psoriasis, psoriatic arthritis, and axial spondyloarthritis) for the treatment of HS…

srdicko

Reducing Overall Mortality by Combining Three Antihypertensives into a Single Pill

Treating hypertension to recommended target blood pressure values often requires a combination of…
26. 6. 2024 Source: Risk factors of cardiovascular diseases
obrazek diabetes

What Benefits Do Modern Antidiabetics Bring to Patients in Primary Care?

How has the life of patients who now have the opportunity to treat diabetes mellitus in general…
21. 6. 2024 Source: Modern Treatment of Diabetes with GLP-1 Analogues
renální kolika

Current European Recommendations for the Treatment of Renal Colic Due to Urolithiasis

At the annual congress in Milan in 2023, new recommendations from the European Association of…
21. 6. 2024 Source: Analgesia
MUDr. Šimon Kozák

MD Šimon Kozák: In algology, nothing works miraculously overnight! It is important to seek advice from specialists

Why is it not advisable to rely on one method in pain treatment? What about patients with a mixed…
21. 6. 2024 Source: Analgesia
eilepsie

Efficacy and Safety of Fenfluramine in the Treatment of Lennox-Gastaut Syndrome – An Overview of Current Knowledge

In a recently published article, British authors summarize the current knowledge on the efficacy…
21. 6. 2024 Source: Rare Diseases in Neurology
epile

Spectrum of Mechanisms of Action of Fenfluramine in the Treatment of Rare Epilepsies

Fenfluramine (FFA) is an anticonvulsant used in the treatment of rare epilepsies such as Dravet…
21. 6. 2024 Source: Rare Diseases in Neurology
osteoartritidy

Hybrid Cooperating Complexes in Osteoarthritis Treatment

Intra-articular application of corticosteroids and hyaluronic acid is part of the treatment of…
21. 6. 2024 Source: Pain Management
Tourette syndrome

Possibilities of Cannabis Use in Tourette Syndrome Therapy

A retrospective analysis and online survey conducted at a psychiatric clinic in Hanover, Germany,…
20. 6. 2024 Source: Medical Cannabis
Artritida

Bimekizumab in the Treatment of Psoriatic Arthritis

Arthritis can appear in up to a third of patients with psoriasis, mostly after the onset of skin…
20. 6. 2024 Source: Rheumatic Diseases
1 2 3 4 5 6 160
Filter by speciality
Remove filters

Conferences

News from the world of medicine

16. 1.
Léčba rány
XIII. Celostátní kongres České společnosti pro léčbu rány s mezinárodní účastí

All conferences
Popular this week
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#